1. Home
  2. STVN vs SNV Comparison

STVN vs SNV Comparison

Compare STVN & SNV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • STVN
  • SNV
  • Stock Information
  • Founded
  • STVN 1949
  • SNV 1888
  • Country
  • STVN Italy
  • SNV United States
  • Employees
  • STVN N/A
  • SNV N/A
  • Industry
  • STVN Containers/Packaging
  • SNV Major Banks
  • Sector
  • STVN Consumer Discretionary
  • SNV Finance
  • Exchange
  • STVN Nasdaq
  • SNV Nasdaq
  • Market Cap
  • STVN 6.6B
  • SNV 6.8B
  • IPO Year
  • STVN 2021
  • SNV N/A
  • Fundamental
  • Price
  • STVN $23.20
  • SNV $48.78
  • Analyst Decision
  • STVN Buy
  • SNV Buy
  • Analyst Count
  • STVN 6
  • SNV 23
  • Target Price
  • STVN $25.08
  • SNV $57.09
  • AVG Volume (30 Days)
  • STVN 294.9K
  • SNV 834.5K
  • Earning Date
  • STVN 08-05-2025
  • SNV 07-16-2025
  • Dividend Yield
  • STVN 0.26%
  • SNV 3.21%
  • EPS Growth
  • STVN N/A
  • SNV 21.31
  • EPS
  • STVN 0.50
  • SNV 3.54
  • Revenue
  • STVN $1,215,562,040.00
  • SNV $1,928,671,000.00
  • Revenue This Year
  • STVN $8.69
  • SNV $28.48
  • Revenue Next Year
  • STVN $10.67
  • SNV $5.42
  • P/E Ratio
  • STVN $48.09
  • SNV $13.66
  • Revenue Growth
  • STVN 3.81
  • SNV N/A
  • 52 Week Low
  • STVN $16.56
  • SNV $35.94
  • 52 Week High
  • STVN $25.75
  • SNV $59.92
  • Technical
  • Relative Strength Index (RSI)
  • STVN 49.43
  • SNV 56.07
  • Support Level
  • STVN $22.70
  • SNV $46.95
  • Resistance Level
  • STVN $24.80
  • SNV $49.83
  • Average True Range (ATR)
  • STVN 1.09
  • SNV 1.01
  • MACD
  • STVN -0.03
  • SNV -0.15
  • Stochastic Oscillator
  • STVN 50.79
  • SNV 68.09

About STVN Stevanato Group S.p.A.

Stevanato Group SpA is a provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries. It delivers an integrated, end-to-end portfolio of products, processes, and services that address customer needs across the entire drug life cycle including development, clinical, and commercial stages. It has two segments; Biopharmaceutical and Diagnostic Solutions which generates key revenue, includes all the products, processes and services developed and provided for the containment and delivery of pharmaceutical and biotechnology drugs and reagents, as well as the production of diagnostic consumables and its other segment is Engineering. Geographically, the company derives majority revenue from Europe, Middle East and Africa.

About SNV Synovus Financial Corp.

Synovus Financial Corp provides commercial and consumer banking in addition to a full suite of specialized products & services such as private banking, treasury management, wealth management, mortgage services, premium finance, asset-based lending, structured lending, capital markets, & international banking to clients through the wholly-owned subsidiary bank, Synovus Bank, and other offices in Alabama, Florida, Georgia, South Carolina, and Tennessee. It has four segments Wholesale Banking, Community Banking, Consumer Banking, and Financial Management Services, out of which the majority is from the Wholesale banking segment.

Share on Social Networks: